CAMTEK LTD (CAMT) Fundamental Analysis & Valuation

NASDAQ:CAMT • IL0010952641

147.31 USD
-17.72 (-10.74%)
At close: Mar 6, 2026
147.31 USD
0 (0%)
After Hours: 3/6/2026, 8:04:14 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CAMT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, CAMT scores 5 out of 10 in our fundamental rating. CAMT was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and the financial health of CAMT get a neutral evaluation. Nothing too spectacular is happening here. CAMT shows excellent growth, but is valued quite expensive already. This makes CAMT very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. CAMT Profitability Analysis

1.1 Basic Checks

  • In the past year CAMT was profitable.
  • In the past 5 years CAMT has always been profitable.
  • CAMT had a positive operating cash flow in 4 of the past 5 years.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • CAMT has a better Return On Assets (4.03%) than 61.74% of its industry peers.
  • CAMT has a better Return On Equity (8.22%) than 67.83% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.82%, CAMT is in the better half of the industry, outperforming 77.39% of the companies in the same industry.
  • CAMT had an Average Return On Invested Capital over the past 3 years of 9.34%. This is in line with the industry average of 10.50%.
Industry RankSector Rank
ROA 4.03%
ROE 8.22%
ROIC 8.82%
ROA(3y)9.1%
ROA(5y)9.89%
ROE(3y)15.44%
ROE(5y)17.53%
ROIC(3y)9.34%
ROIC(5y)10.06%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • CAMT has a better Profit Margin (10.22%) than 66.09% of its industry peers.
  • CAMT's Profit Margin has declined in the last couple of years.
  • CAMT has a better Operating Margin (25.94%) than 84.35% of its industry peers.
  • In the last couple of years the Operating Margin of CAMT has grown nicely.
  • Looking at the Gross Margin, with a value of 50.56%, CAMT is in the better half of the industry, outperforming 63.48% of the companies in the same industry.
  • CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.94%
PM (TTM) 10.22%
GM 50.56%
OM growth 3Y0.71%
OM growth 5Y12.32%
PM growth 3Y-25.69%
PM growth 5Y-6.06%
GM growth 3Y0.5%
GM growth 5Y1.48%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CAMT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CAMT is destroying value.
  • Compared to 1 year ago, CAMT has more shares outstanding
  • CAMT has more shares outstanding than it did 5 years ago.
  • CAMT has a worse debt/assets ratio than last year.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 8.96 indicates that CAMT is not in any danger for bankruptcy at the moment.
  • CAMT's Altman-Z score of 8.96 is fine compared to the rest of the industry. CAMT outperforms 70.43% of its industry peers.
  • CAMT has a Debt/Equity ratio of 0.84. This is a neutral value indicating CAMT is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.84, CAMT is not doing good in the industry: 82.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 8.96
ROIC/WACC0.72
WACC12.2%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 8.35 indicates that CAMT has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 8.35, CAMT belongs to the best of the industry, outperforming 86.09% of the companies in the same industry.
  • CAMT has a Quick Ratio of 7.31. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CAMT (7.31) is better than 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 8.35
Quick Ratio 7.31
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. CAMT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 14.23% over the past year.
  • The Earnings Per Share has been growing by 38.06% on average over the past years. This is a very strong growth
  • The Revenue has grown by 15.65% in the past year. This is quite good.
  • Measured over the past years, CAMT shows a very strong growth in Revenue. The Revenue has been growing by 26.06% on average per year.
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
Revenue 1Y (TTM)15.65%
Revenue growth 3Y15.63%
Revenue growth 5Y26.06%
Sales Q2Q%9.23%

3.2 Future

  • Based on estimates for the next years, CAMT will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.24% on average per year.
  • The Revenue is expected to grow by 15.15% on average over the next years. This is quite good.
EPS Next Y5.77%
EPS Next 2Y10.58%
EPS Next 3Y12.83%
EPS Next 5Y14.24%
Revenue Next Year6.12%
Revenue Next 2Y10.27%
Revenue Next 3Y13.94%
Revenue Next 5Y15.15%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

2

4. CAMT Valuation Analysis

4.1 Price/Earnings Ratio

  • CAMT is valuated quite expensively with a Price/Earnings ratio of 45.89.
  • CAMT's Price/Earnings ratio is a bit cheaper when compared to the industry. CAMT is cheaper than 61.74% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, CAMT is valued quite expensively.
  • CAMT is valuated quite expensively with a Price/Forward Earnings ratio of 43.39.
  • CAMT's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, CAMT is valued quite expensively.
Industry RankSector Rank
PE 45.89
Fwd PE 43.39
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CAMT does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of CAMT may justify a higher PE ratio.
  • CAMT's earnings are expected to grow with 12.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.96
PEG (5Y)1.21
EPS Next 2Y10.58%
EPS Next 3Y12.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CAMT Dividend Analysis

5.1 Amount

  • CAMT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAMT Fundamentals: All Metrics, Ratios and Statistics

CAMTEK LTD

NASDAQ:CAMT (3/6/2026, 8:04:14 PM)

After market: 147.31 0 (0%)

147.31

-17.72 (-10.74%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-18
Earnings (Next)05-11
Inst Owners56.76%
Inst Owner Change-2.77%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap6.74B
Revenue(TTM)496.07M
Net Income(TTM)50.72M
Analysts82.22
Price Target177.31 (20.37%)
Short Float %11.05%
Short Ratio5.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.33
Dividend Growth(5Y)56.74%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.12%
Min EPS beat(2)-2.36%
Max EPS beat(2)0.11%
EPS beat(4)2
Avg EPS beat(4)-1%
Min EPS beat(4)-2.36%
Max EPS beat(4)0.51%
EPS beat(8)6
Avg EPS beat(8)1.58%
EPS beat(12)9
Avg EPS beat(12)2.04%
EPS beat(16)12
Avg EPS beat(16)1.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-0.59%
Revenue beat(8)2
Avg Revenue beat(8)-0.4%
Revenue beat(12)2
Avg Revenue beat(12)-0.58%
Revenue beat(16)2
Avg Revenue beat(16)-0.83%
PT rev (1m)33.8%
PT rev (3m)37.09%
EPS NQ rev (1m)-2.01%
EPS NQ rev (3m)-1.95%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-3.97%
Revenue NQ rev (1m)2.6%
Revenue NQ rev (3m)1.97%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 45.89
Fwd PE 43.39
P/S 13.59
P/FCF N/A
P/OCF N/A
P/B 10.93
P/tB 12.66
EV/EBITDA N/A
EPS(TTM)3.21
EY2.18%
EPS(NY)3.4
Fwd EY2.3%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.84
BVpS13.48
TBVpS11.64
PEG (NY)7.96
PEG (5Y)1.21
Graham Number31.2
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 8.22%
ROCE 11.17%
ROIC 8.82%
ROICexc 21%
ROICexgc 25.43%
OM 25.94%
PM (TTM) 10.22%
GM 50.56%
FCFM N/A
ROA(3y)9.1%
ROA(5y)9.89%
ROE(3y)15.44%
ROE(5y)17.53%
ROIC(3y)9.34%
ROIC(5y)10.06%
ROICexc(3y)18.07%
ROICexc(5y)29.31%
ROICexgc(3y)22.71%
ROICexgc(5y)32.19%
ROCE(3y)11.82%
ROCE(5y)12.73%
ROICexgc growth 3Y-9.39%
ROICexgc growth 5Y-5.81%
ROICexc growth 3Y-14.91%
ROICexc growth 5Y-9.14%
OM growth 3Y0.71%
OM growth 5Y12.32%
PM growth 3Y-25.69%
PM growth 5Y-6.06%
GM growth 3Y0.5%
GM growth 5Y1.48%
F-ScoreN/A
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.35
Quick Ratio 7.31
Altman-Z 8.96
F-ScoreN/A
WACC12.2%
ROIC/WACC0.72
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
EPS Next Y5.77%
EPS Next 2Y10.58%
EPS Next 3Y12.83%
EPS Next 5Y14.24%
Revenue 1Y (TTM)15.65%
Revenue growth 3Y15.63%
Revenue growth 5Y26.06%
Sales Q2Q%9.23%
Revenue Next Year6.12%
Revenue Next 2Y10.27%
Revenue Next 3Y13.94%
Revenue Next 5Y15.15%
EBIT growth 1Y17.96%
EBIT growth 3Y16.45%
EBIT growth 5Y41.58%
EBIT Next Year10.23%
EBIT Next 3Y14.63%
EBIT Next 5Y18.73%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CAMTEK LTD / CAMT FAQ

What is the fundamental rating for CAMT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CAMT.


What is the valuation status of CAMTEK LTD (CAMT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CAMTEK LTD (CAMT). This can be considered as Overvalued.


How profitable is CAMTEK LTD (CAMT) stock?

CAMTEK LTD (CAMT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CAMT stock?

The Price/Earnings (PE) ratio for CAMTEK LTD (CAMT) is 45.89 and the Price/Book (PB) ratio is 10.93.


What is the financial health of CAMTEK LTD (CAMT) stock?

The financial health rating of CAMTEK LTD (CAMT) is 5 / 10.